Streamlining Information in the Pharmaceutical Industry with PLM (Review Report):

Streamlining Information in the Pharmaceutical Industry with PLM (Review Report)

Published Date: August 2007

Published By: Datamonitor

Page Count: 67

Order Code: R313-25026

Questions About This Report

E-mail a Colleague

Printable Page

Fax Your Order

Description

Table of Contents

Search Inside
this Report

Similar
Products

Overview: Catalyst; Summary; Methodology; Executive Summary; Introduction; From Idea to Market: Product Lifecycle Management in the Pharmaceutical Industry (Market Focus); Optimizing PLM Technology for the Pharmaceutical Industry (Technology Focus); Managing Process Complexity with PLM (Strategy Focus); Pharmaceutical Product Lifecycle Management Forecast in North America 2006-2012 (Databook); Pharmaceutical Product Lifecycle Management Forecast in Western Europe 2006-2012; Pharmaceutical Product Lifecycle Management Forecast in APAC 2006-2012; Table of Contents; Table of figures; Table of tables; From Idea to Market: Product Lifecycle Management in the Pharmaceutical Industry (market focus); Summary; Product lifecycle management will transform the drug development lifecycle process; The nature of a drug's lifecycle necessitates a PLM strategy; PLM addresses key business challenges facing the pharmaceutical industry; A greater focus on decreasing time to market is driving adoption of PLM; Harmonizing product portfolios from M&A activities sets the stage for PLM; Reducing the challenges and cost associated with regulatory compliance; The nature of the pharmaceutical drug pipeline is changing; Complexity of pharmaceutical products is increasing; The end of the Blockbuster era signifies more candidates in the pipeline; Successful PLM for the pharmaceutical industry prevails over several constraining factors; Repurposing software from other industries makes the pharmaceutical industry suspicious; The traditional autonomous-business-unit mentality inhibits adoption of PLM; PLM does not mean an antidote to new product development
ACTIONS: Articulate strategic business benefits of your PLM investment decisions; Take a holistic approach to PLM; Understand how PLM changes the lifecycle processes of a pharmaceutical product; Optimizing PLM Technology for the Pharmaceutical Industry (technology Focus); Summary; PLM technology should align to the pharmaceutical industry's business challenges; Digitizing research information earlier in the product lifecycle is an essential first step towards PLM; The electronic notebook offers an entry point to a connected and global product management system; PLM links disparate technologies offering a single point of truth for each drug in development; Alleviating risks of non-compliance is a key application for PLM in the pharmaceutical industry; Six technology features reflect how PLM technology is aligned to the industry; Scalability places SOA at the center of a PLM solution; A quality-by-design feature facilitates compliance; PLM must integrate with ERP solutions; A web-enabled PLM solution matches the global nature of most pharmaceutical organizations; A easy-to-configure user interface drives adoption amongst both scientists and engineers; The industry is most comfortable with non-hosted solutions; PLM technology adoption differs across geographies; Japan and China will experience the fastest growth in PLM
ACTIONS: Offer technology features that speak to the customer's business goals; Make PLM a core part of the customer's every day life; Consider geography as a criterion for prioritizing your target market; Managing Process Complexity with PLM (Strategy Focus); Summary; Pharmaceutical product lifecycle management technology is gaining momentum; A variety of challenges is fueling PLM adoption in the pharmaceutical industry; Cultural and technological barriers have inhibited wider adoption of PLM in the pharmaceutical market; PLM in the pharmaceutical industry is poised for strong growth and vendors have an important role to play; PLM in the life sciences should map to business processes, managing process complexity; Pharmaceutical companies produce what they discover, not what they invent; The pharmaceutical sector looks for PLM that can manage process complexity; PLM is successful when handled as an enterprise, strategic initiative; As part of a company's product development business strategy, PLM is discussed among executives; Collaboration, through enterprise PLM, breaks down individual silos; Reducing drug development costs is a major strategic goal for implementing enterprise PLM; The benefits of an enterprise-wide PLM solution do come with risks; A phased implementation approach is most likely for pharmaceutical organizations; Partnering with a technology vendor may be a necessary PLM strategy; A long-term commitment to the project indicates a willingness to share risk; Innovative and flexible vendors will attract most business; Implementation efficiency is an important vendor characteristic; Track record of success reflects on a vendor's reliability and trustworthiness
ACTIONS: PLM must support executive-level decisions; Have a long-term vision but establish short-term milestones; Look beyond point solutions for a strategic approach to PLM; Pharmaceutical Product Lifecycle Management Forecast in North America 2006-2012 (Databook); Summary
iNTRODUCTION: Definitions; Total PLM spending in the pharmaceutical industry in North America; Total pharmaceutical PLM spending in North America by technology segment; US PLM spending in the pharmaceutical industry 2006-2012; Canada PLM spending in the pharmaceutical industry 2006-2012; Total North America PLM spending in the pharmaceutical industry by sector; Global PLM spending by geographic region; Pharmaceutical Product Lifecycle Management Forecast in Western Europe 2006-2012 (Databook); Summary
iNTRODUCTION: Definitions; Total PLM spending in the pharmaceutical industry in Western Europe; Total pharmaceutical PLM spending in Western Europe by technology segment; Total pharmaceutical PLM spending in Western Europe by sector; France PLM spending in the pharmaceutical industry 2006-2012; Germany PLM spending in the pharmaceutical industry 2006-2012; UK PLM spending in the pharmaceutical industry 2006-2012; Italy PLM spending in the pharmaceutical industry 2006-2012; Spain PLM spending in the pharmaceutical industry 2006-2012; Switzerland PLM spending in the pharmaceutical industry 2006-2012; Global PLM spending by geographic region; Pharmaceutical Product Lifecycle Management Forecast in APAC 2006-2012 (Databook); Summary
iNTRODUCTION: Definitions; Global PLM spending by geographic region; Total PLM spending in the pharmaceutical industry in APAC; China PLM spending in the pharmaceutical industry 2006-2012; Japan PLM spending in the pharmaceutical industry 2006-2012; Total APAC PLM spending in the pharmaceutical industry by sector
APPENDIX: Definitions; Abbreviations; Methodology; Further reading; Ask the analyst; Datamonitor consulting; Disclaimer
List of Tables: Table 1: Total PLM spending in the pharmaceutical industry in North America; Table 2: Total pharmaceutical PLM spending in North America by technology segment; Table 3: US PLM spending in the pharmaceutical industry 2006-2012; Table 4: Canada PLM spending in the pharmaceutical industry 2006-2012; Table 5: Total North America PLM spending in the pharmaceutical industry by sector; Table 6: Global PLM spending by geographic region; Table 7: Total PLM spending in the pharmaceutical industry in Western Europe; Table 8: Total pharmaceutical PLM spending in Western Europe by technology segment; Table 9: Total pharmaceutical PLM spending in Western Europe by sector 2006-2012; Table 10: France PLM spending in the pharmaceutical industry 2006-2012; Table 11: Germany PLM spending in the pharmaceutical industry 2006-2012; Table 12: UK PLM spending in the pharmaceutical industry 2006-2012; Table 13: Italy PLM spending in the pharmaceutical industry 2006-2012; Table 14: Spain PLM spending in the pharmaceutical industry 2006-2012; Table 15: Switzerland PLM spending in the pharmaceutical industry 2006-2012; Table 16: Global PLM spending by geographic region; Table 17: Global PLM spending by geographic region; Table 18: Total PLM spending in the pharmaceutical industry in APAC; Table 19: China spending in the pharmaceutical industry 2006-2012; Table 20: Japan PLM spending in the pharmaceutical industry 2006-2012; Table 21: Total North America PLM spending in the pharmaceutical industry by sector
List of Figures: Figure 1: The pharmaceutical product lifecycle is highly regulated, more complex and longer than other industries; Figure 2: Drug discovery licensing dependence of the top 10 pharmaceutical companies; Figure 3: PLM spending in the pharmaceutical market is set for strong growth over the next five years; Figure 4: PLM in relation to ERP, CRM and BI; Figure 5: PLM software must evolve to configurable packages to better meet the pharmaceutical industry's needs; Figure 6: Global PLM spending by geographic region; Figure 7: In the pharmaceutical industry, complexity in the process defines the product; Figure 8: Making a value proposition for PLM as a strategy in the pharmaceutical product lifecycle; Figure 9: As the Big Pharma begins to face its information management needs, enterprise PLM investments will grow; Figure 10: Examples of ""must-have"" and ""nice-to-have"" criteria pharmaceutical companies use for selecting a PLM vendor as potential partner; Figure 11: Total PLM spending in the pharmaceutical industry in North America; Figure 12: Total pharmaceutical PLM spending in North America by technology segment; Figure 13: US PLM spending in the pharmaceutical industry 2006-2012; Figure 14: Canada PLM spending in the pharmaceutical industry 2006-2012; Figure 15: Total North America PLM spending in the pharmaceutical industry by sector; Figure 16: Global PLM spending by geographic region; Figure 17: Total PLM spending in the pharmaceutical industry in Western Europe; Figure 18: Total pharmaceutical PLM spending in Western Europe by technology segment; Figure 19: Total pharmaceutical PLM spending in Western Europe by sector 2006-2012; Figure 20: France PLM spending in the pharmaceutical industry 2006-2012; Figure 21: Germany PLM spending in the pharmaceutical industry 2006-2012; Figure 22: UK PLM spending in the pharmaceutical industry 2006-2012; Figure 23: Italy PLM spending in the pharmaceutical industry 2006-2012; Figure 24: Spain PLM spending in the pharmaceutical industry 2006-2012; Figure 25: Switzerland PLM spending in the pharmaceutical industry 2006-2012; Figure 26: Global PLM spending by geographic region; Figure 27: Global PLM spending by geographic region; Figure 28: Total PLM spending in the pharmaceutical industry in APAC; Figure 29: China spending in the pharmaceutical industry 2006-2012; Figure 30: Japan PLM spending in the pharmaceutical industry 2006-2012; Figure 31: Total APAC PLM spending in the pharmaceutical industry by sector

	Research Index \| Publishers \| My Account \| Contact Us \| About MindBranch
	Welcome Guest (Login/Register) \| 0 items